Redpoint Bio (RPBC) Stock Price, News & Analysis

Company Overview

Redpoint Bio (OTCMKTS: RPBC) is a development‐stage biopharmaceutical company focused on advancing novel immuno‐oncology therapies. The firm’s primary business activity centers on leveraging the human immune system to create targeted treatments designed to improve outcomes for cancer patients.

Redpoint Bio’s research and development efforts employ proprietary technology platforms aimed at modulating the tumor microenvironment to enhance anti‐tumor immune responses. Its pipeline comprises multiple product candidates across discovery and early clinical development stages, each engineered to address unmet needs in oncology.

Based in the United States, Redpoint Bio partners with academic institutions and industry collaborators to accelerate the progression of its drug candidates. Publicly available information on the company’s history, leadership team and specific program details remains limited.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0001
• Volume: 200,000 shs
• Average Volume: 101,150 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RPBC Stock Analysis - Frequently Asked Questions

How have RPBC shares performed this year?

Redpoint Bio's stock was trading at $0.0001 at the start of the year. Since then, RPBC stock has increased by 0.0% and is now trading at $0.0001.

How do I buy shares of Redpoint Bio?

Shares of RPBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Redpoint Bio own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Redpoint Bio investors own include Twitter (TWTR), Towne Bank (TOWN), Hershey (HSY), Ferro (FOE) and BMC Stock (BMCH).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Commercial Physical Research
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:RPBC
• CIK: 1328003
• Web: www.redpointbio.com
• Phone: 215-456-2312
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A